Stable Polyelectrolyte Coated Nanoparticles
The approach:ΓÇóProvides a universal and an efficient platform for making stable drug colloidsΓÇóEnables an effective break down of drug particles into nano-size pieces, which are then prevented from self-aggregatingΓÇóIs associated with a higher loading efficacy as compared to conventional approachesΓÇóEffectively enables combination of two or more drugs into one nano-particleΓÇóWould be commercially useful for treatment/screening of variety of disorders such as breast cancer, prostate cancer, lung cancer, lymphomas, skin cancer, pancreatic cancer, colon cancer, melanoma, ovarian cancer, brain cancer, head and neck cancer, liver cancer, bladder cancer, non-small lung cancer, cervical carcinoma, leukemia, non-HodgkinΓÇÖs lymphoma, multiple sclerosis, neuroblastoma and glioblastoma, T and B cell mediated autoimmune diseases, inflammatory diseases, infections, hyper-proliferative diseases, AIDS, degenerative conditions, cardiovascular diseases, and transplant rejection
None
美国
